Chronic obstructive pulmonary disease (COPD)1 is the fourth leading cause of death in the United States and the third most common cause of hospital readmissions among Medicare beneficiaries.2,3 Given the impaired quality of life experienced by patients living with COPD and the costs to the health care system attributable to COPD, there is a strong need to explore interventions beyond currently available pharmacotherapies, supplemental oxygen, and pulmonary rehabilitation. The use of noninvasive positive pressure ventilation (NIPPV) in patients with COPD has been an area of increasing interest over the past 3 decades.4
Coleman JM, Gates KL, Kalhan R. Home Noninvasive Ventilation for Patients With Chronic Obstructive Pulmonary Disease and Chronic Respiratory Failure. JAMA. 2020;323(5):421–422. doi:10.1001/jama.2019.22484
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: